TrialOpen forum infectious diseases2024

Efficacy of Fecal Microbiota, Live-jslm (REBYOTA®), Among Patients Exposed to Non-

Kelly R Reveles et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.